Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 1

3029 - The molecular landscape of fusion genes in endometrial stromal sarcomas include three nosological entities with different natural history

Date

28 Sep 2019

Session

Poster Display session 1

Topics

Tumour Site

Sarcoma

Presenters

Mehdi Brahmi

Citation

Annals of Oncology (2019) 30 (suppl_5): v683-v709. 10.1093/annonc/mdz283

Authors

M. Brahmi1, T. Franceschi2, I. TREILLEUX3, D. Pissaloux4, I.L. Ray-Coquard5, A. Dufresne5, P. Meeus6, M. Sunyach7, K. Marie8, A. Meurgey2, J. Blay9, F. Tirode10

Author affiliations

  • 1 Medical Oncology, Centre Léon Bérard, 69008 - LYON/FR
  • 2 Pathology, Centre Léon Bérard, 69008 - LYON/FR
  • 3 Pathology, Centre Léon Bérard, 69008 - Lyon/FR
  • 4 Biopathology, Centre Léon Bérard, 69008 - LYON/FR
  • 5 Medical Oncology, Centre Léon Bérard, 69008 - Lyon/FR
  • 6 Surgical Oncology, Centre Léon Bérard, 69008 - Lyon/FR
  • 7 Radiotherapy, Centre Léon Bérard, 69008 - LYON/FR
  • 8 Pathology, Centre Leon Berard, Lyon/FR
  • 9 Medicine, Centre Léon Bérard, 69008 - Lyon/FR
  • 10 Inserm 1052, Cnrs 5286, Cancer Research Center Of Lyon, Centre Léon Bérard, 69008 - LYON/FR
More

Resources

Abstract 3029

Background

About half of ESS do not harbor a JAZF1 or YWHAE fusion and other rearrangements have already been reported. With the aim to provide a comprehensive description of the molecular landscape of endometrial stromal sarcomas (ESS), we investigated by RNA-sequencing a series of tumors diagnosed as ESS based on the morphology but negative for JAZF1 and/or YWHAE in FISH experiments.

Methods

This study was performed between September 2017 and December 2018 as a Centre Léon Bérard monocentric retrospective translational research program on tumor samples from an investigational cohort of 43 ESS patients. For clustering analyses, we used a control cohort composed of 19 patient samples of BCOR-rearranged sarcomas (n = 8), low-grade ESS with JAZF1-SUZ12 fusion (n = 5), high-grade ESS carrying a BCOR internal tandem duplication (n = 1), uterine leiomyoma (n = 2) and uterine leiomyosarcomas (n = 3). RNA sequencing was performed from FFPE material in all cases using TruSeq RNA Access Library Prep Kit (Illumina®).

Results

A chromosomal rearrangement was identified in 74% of the cases (n = 32). We identified biologically homogeneous groups of tumors such as the JAZF1-fused (to PHF1 and SYNGAP1) and the BCOR-rearranged (BCOR-ITD, ZC3H7B-BCOR, CREBBP-BCOR). Using a clustering approach on transcriptomic data, tumors were divided in 3 subgroups: one mainly composed of BCOR-rearranged ESS (n = 7), one mainly composed of JAZF1-fused ESS (n = 14) and one composed of various molecular subtypes (n = 22). This 3 subgroups display significantly different survivals (Log-rank test, p = 0.004). Five cases which harbored a YWAHE-NUTM2B fusions clustered separately: 3 cases in the group of indolent tumors (JAZF1-fused ESS) and 2 cases in the group of aggressive tumors (BCOR-rearranged sarcomas). Of note, those 2 cases harbored also a single nucleotide variant, one on BCOR and one on BCORL1. Results of RNA-seq and clustering analysis have allowed a better classification in 6 cases.

Conclusions

This is the largest series of RNAseq performed in a very rare subtype of tumors: ESS. We report new and recurrent molecular variants of ESS including previously unreported fusions. RNA-sequencing may support the diagnosis of ESS and help a better classification.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

InterSARC grants.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.